BMC Infectious Diseases is called for submissions to our Collection on Long-term effects of COVID-19 infections.
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global healthcare crisis and strained health resources. As the population of patients recovering from COVID-19 grows, it is important to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations, and similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. This phenomenon is now referred to as post-acute COVID-19 or post-COVID syndrome and is characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms that include but are not limited to fatigue, chest pain, dyspnea, cognitive disturbances, arthralgia, and a decline in quality of life.
We were particularly interested in manuscripts that address the following topics:
- Identification and characterization of key clinical, serological, imaging and epidemiological features of COVID-19 in the chronic phase of disease.
- Clinical studies, including prospective cohorts and clinical trials, that help us to better understand the pathophysiology of this disease.
- Investigation and management of symptoms and organ-specific complications that developed after the acute phase of COVID-19.
- Manuscripts covering Interdisciplinary cooperation and comprehensive care and rehabilitation of patients with post-COVID-19 syndrome in the outpatient setting.
This call for papers invited submissions from researchers and practitioners in the field of post-COVID syndrome, including epidemiology, clinical medicine and public health. We welcomed scientifically sound original research articles and systematic reviews. This collection did not consider Case Reports.
Note: For the scope of this collection, post-COVID-19 syndrome was defined as persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms.
Image credit: © freshidea / stock.adobe.com